| International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, ... Blood, The Journal of the American Society of Hematology 126 (3), 291-299, 2015 | 1318 | 2015 |
| The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study L Pagano, M Caira, A Candoni, M Offidani, L Fianchi, B Martino, ... Haematologica 91 (8), 1068-1075, 2006 | 1272 | 2006 |
| Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1 AJM Ferreri, E Campo, JF Seymour, R Willemze, F Ilariucci, A Ambrosetti, ... British journal of haematology 127 (2), 173-183, 2004 | 643 | 2004 |
| Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ... The Lancet Haematology 7 (10), e737-e745, 2020 | 552 | 2020 |
| Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia R Foa, A Vitale, M Vignetti, G Meloni, A Guarini, MS De Propris, L Elia, ... Blood, The Journal of the American Society of Hematology 118 (25), 6521-6528, 2011 | 495 | 2011 |
| Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne L Pagano, M Caira, A Nosari, MT Van Lint, A Candoni, M Offidani, T Aloisi, ... Clinical Infectious Diseases 45 (9), 1161-1170, 2007 | 494 | 2007 |
| Mucormycosis in hematologic patients L Pagano, M Offidani, L Fianchi, A Nosari, A Candoni, M Picardi, ... haematologica 89 (2), 207-214, 2004 | 480* | 2004 |
| Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study L Pagano, M Caira, A Candoni, M Offidani, B Martino, G Specchia, ... haematologica 95 (4), 644, 2010 | 376 | 2010 |
| Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey EM Trecarichi, L Pagano, A Candoni, D Pastore, C Cattaneo, R Fanci, ... Clinical Microbiology and Infection 21 (4), 337-343, 2015 | 236 | 2015 |
| Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GINEMA infection program DL Pagano, C Girmenia, L Mele, P Ricci, ME Tosti, A Nosari, M Buelli, ... haematologica 86 (8), 862-870, 2001 | 212 | 2001 |
| Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy C Girmenia, GM Rossolini, A Piciocchi, A Bertaina, G Pisapia, D Pastore, ... Bone marrow transplantation 50 (2), 282-288, 2015 | 175 | 2015 |
| Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease OA Cornely, RF Duarte, S Haider, P Chandrasekar, D Helfgott, ... Journal of Antimicrobial Chemotherapy 71 (3), 718-726, 2016 | 170 | 2016 |
| GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia A Venditti, A Piciocchi, A Candoni, L Melillo, V Calafiore, R Cairoli, ... Blood, The Journal of the American Society of Hematology 134 (12), 935-945, 2019 | 169 | 2019 |
| Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years N Vianelli, F Palandri, N Polverelli, R Stasi, J Joelsson, E Johansson, ... haematologica 98 (6), 875, 2013 | 154 | 2013 |
| Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality—SEIFEM-C Report L Pagano, M Caira, M Picardi, A Candoni, L Melillo, L Fianchi, M Offidani, ... Clinical Infectious Diseases 44 (11), 1524-1525, 2007 | 143 | 2007 |
| Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective … C Girmenia, A Bertaina, A Piciocchi, K Perruccio, A Algarotti, A Busca, ... Clinical Infectious Diseases 65 (11), 1884-1896, 2017 | 140 | 2017 |
| Bloodstream infections caused by Klebsiella pneumoniae in onco‐hematological patients: clinical impact of carbapenem resistance in a multicentre prospective … EM Trecarichi, L Pagano, B Martino, A Candoni, R Di Blasi, G Nadali, ... American journal of hematology 91 (11), 1076-1081, 2016 | 133 | 2016 |
| Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients L Potenza, D Vallerini, P Barozzi, G Riva, F Forghieri, E Zanetti, ... Blood, The Journal of the American Society of Hematology 118 (20), 5416-5419, 2011 | 128 | 2011 |
| Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid … A Candoni, M Tiribelli, E Toffoletti, D Cilloni, A Chiarvesio, A Michelutti, ... European journal of haematology 82 (1), 61-68, 2009 | 119 | 2009 |
| The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’patients with intravascular large B‐cell lymphoma AJM Ferreri, GP Dognini, O Bairey, A Szomor, C Montalbán, B Horvath, ... British journal of haematology 143 (2), 253-257, 2008 | 118 | 2008 |
